Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
Reading time: 1 minute
Two trials with a total of 40 patients were included in a Cochrane review 1
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
{{branchArticle.articleDatabase.name}}
Article ID:{{branchArticle.id}}
{{branchArticle.publishedStr}}
Authors: {{branchArticle.authors}}
Copyright © Dental Mammoth. All Rights Reserved
Copyright © Duodecim Medical Publications Ltd. 2018. All Rights Reserved
Table of contents
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
Evidence Summaries
Article ID: evd02441
Published 11.08.2003
Authors: Editors
Copyright © Duodecim Medical Publications Ltd. All Rights Reserved
{{selectedMetadata.pluginDescription || selectedMetadata.metaId}}
{{metaDataError}}
|
|